A5014693230- Chronic Lymphocytic Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Transplantation: Methods and Outcomes
- Polyomavirus and related diseases
- Immunodeficiency and Autoimmune Disorders
- T-cell and Retrovirus Studies
- Eosinophilic Disorders and Syndromes
- Acute Myeloid Leukemia Research
- Lymphoma Diagnosis and Treatment
- Neurogenetic and Muscular Disorders Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Advanced Breast Cancer Therapies
Hospital Santa Marcelina
2005-2019
Ghent University Hospital
2011
Mount Vernon Cancer Centre
2011
Nihon University
2011
The University of Texas MD Anderson Cancer Center
2011
Bnai Zion Medical Center
2011
Hospital São Paulo
2011
Universidade Federal de São Paulo
2007-2009
Allogeneic hematopoietic stem cell transplantation (AHSCT) is the treatment of choice for young patients with severe aplastic anemia (SAA). The association antithymocyte globulin (ATG) and cyclophosphamide (CY) most frequently used conditioning regimen this disease. We performed retrospective study in order to compare outcomes HLA-matched sibling donor AHSCT 41 SAA receiving plus ATG (ATG-CY, N = 17) or busulfan (BU-CY, 24). substitution BU was motivated by high cost ATG. There were no...
We report a retrospective study of the clinical features and outcome for 32 allogeneic stem cell transplants (AlloSCT) from HLA-matched sibling donors in severe aplastic anemia conditioned with 200 mg/kg cyclophosphamide plus 90 horse antithymocyte globulin (ATG) 17 patients 120 12 busulfan (Bu) 15 patients, at Hospital São Paulo Santa Marcelina, November 1993 to August 2003. Considering high cost ATG difficulty obtain it majority our centers, objective was compare variables as age, sex,...